{"id":181822,"date":"2024-02-01T02:22:32","date_gmt":"2024-02-01T08:22:32","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/02\/diabetes-medication-class-tied-to-lower-risk-of-kidney-stones"},"modified":"2024-02-01T02:22:32","modified_gmt":"2024-02-01T08:22:32","slug":"diabetes-medication-class-tied-to-lower-risk-of-kidney-stones","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/02\/diabetes-medication-class-tied-to-lower-risk-of-kidney-stones","title":{"rendered":"Diabetes medication class tied to lower risk of kidney stones"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/diabetes-medication-class-tied-to-lower-risk-of-kidney-stones3.jpg\"><\/a><\/p>\n<p>Rates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit of lowering risk of kidney stones.<\/p>\n<p>In a study led by investigators from Mass General Brigham, researchers found that there was an association between the use of sodium-glucose contratransporter 2 (SGLT2) inhibitors and a lower risk of developing <a href=\"https:\/\/medicalxpress.com\/tags\/kidney+stones\/\" rel=\"tag\" class=\"\">kidney stones<\/a>. Their findings are <a href=\"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2814491\">reported<\/a> in <i>JAMA Internal Medicine.<\/i><\/p>\n<p>Researchers from Brigham and Women\u2019s Hospital and Massachusetts General Hospital worked together to conduct the analysis. The study included data from three nationwide databases of patients with type 2 <a href=\"https:\/\/medicalxpress.com\/tags\/diabetes\/\" rel=\"tag\" class=\"\">diabetes<\/a> who were seen in routine clinical practice. The team analyzed information from 716,406 adults with type 2 diabetes who had started taking an SGLT2 inhibitor or two other classes of diabetes medications known as GLP1 receptor agonists or dipeptidyl peptidase 4 (DPP4) inhibitors.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit of lowering risk of kidney stones. In a study led by investigators from Mass General [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-181822","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/181822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=181822"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/181822\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=181822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=181822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=181822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}